glp 1 agonist or antagonist Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Glucagon-like peptide-1 receptor: mechanisms and
Description
Committing to a healthy diet and regular exercise is the most effective strategy for long-term weight management
The most pronounced inhibitory effects were observed at concentrations of 10 and 100 nM for each compound
Imbroane, M
Urban population growth and dietary shifts are increasing obesity prevalence rates, creating expanding demand for medical weight management interventions
However, an effort to change this and allow Medicare to cover obesity medications is within the Federal Treat and Reduce Obesity Act legislation (see sidebar Resources).1 Reference 1
10.1073/pnas.84.20.7005
